Daniel Kolditz

Daniel Kolditz serves as CTO at AB-CT - Advanced Breast-CT. AB-CT - Advanced Breast-CT operates in the medical devices sector with approximately 31.0 employees. The company is headquartered in Nuremberg, Bavaria.

Industry & Role Insights

• • MessageCEO tracks 1,888 executives in the medical devices sector.
• • 1,671 executive contacts are available in Bavaria.
• • Our database includes 201,469 c suite-level executives.

Outlook Vimeo WordPress.org Apache Mobile Friendly Facebook Login (Connect) Google Tag Manager Facebook Widget Remote

medical equipment manufacturing breast imaging 3d imaging computed tomography breast ct low radiation dose high patient comfort isotropic resolution photon-counting technology clinical integration soft-tissue differentiation compression-free examination real-time imaging scan times medical technology early diagnosis breast cancer detection patient-centered care diagnostic solutions 3d breast ct cad visualization ris integration pacs integration diagnostic imaging medical physics research volumetric imaging ce marked technology image quality rapid diagnosis healthcare innovation disease detection clinical cases medical device medical imaging radiology practice advanced imaging mammogram alternatives spiral ct technology detection sensitivity patient reassurance image reconstruction direct conversion detectors detection efficacy radiological diagnostics mammography alternatives breast density analysis clinical application healthcare professionals innovative imaging solutions advanced diagnosis medical devices hospital & health care

YM

Yahia Megahed CEO at 360Imaging

HA

Hugo Azevedo Chief Technology Officer at 3B Scientific

MP

Marie-Laure Pochon CEO & President at 3DISC

KD

Khanh Duy Co-CEO at 3D-Side

K

Khanh Co-CEO at 3D-Side

Outreach Guidance — medical devices Sector

Executives like Daniel Kolditz in the medical devices sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at AB-CT - Advanced Breast-CT.

Daniel Kolditz's Position in the MessageCEO Database

• •Daniel Kolditz is 1 of 1 verified executive contact we track at AB-CT - Advanced Breast-CT.
• •1,787 verified executive contacts in medical devices are in the MessageCEO database.
• •1,664 verified executive contacts in Bavaria are in the database.
• •31 verified contacts work at medical devices companies in the 31.0 employee range (same size as AB-CT - Advanced Breast-CT).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated May 2026.

How do I reach Daniel Kolditz directly?

Daniel Kolditz's verified email address is available to MessageCEO Pro subscribers. They currently serve as CTO at AB-CT - Advanced Breast-CT. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Daniel Kolditz work for?

Daniel Kolditz is CTO at AB-CT - Advanced Breast-CT, a company in the medical devices sector with 31.0 employees. The company is based in Nuremberg, Bavaria.

Can I pitch or sell to Daniel Kolditz?

As CTO at AB-CT - Advanced Breast-CT, Daniel Kolditz is a key decision-maker in the medical devices sector. MessageCEO Pro gives you verified email to reach Daniel Kolditz directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Daniel Kolditz in?

Daniel Kolditz works in the medical devices industry as CTO at AB-CT - Advanced Breast-CT. MessageCEO provides verified contact information for executives across all major industries.

Is Daniel Kolditz's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Daniel Kolditz's profile is kept up-to-date with the latest available information.

Last updated: May 26, 2026